TECHNOLOGY LICENSING OPPORTUNITY: Protein-Based Rare Earth Recovery via Condensation

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

TRIAD - DOE CONTRACTOR

Contract Value

Not provided

Codes & Classification
Solicitation Number

S-193669

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Classification Code

AJ12

Additional Details
Set Aside

NONE

Place of Performance

Los Alamos, New Mexico, UNITED STATES

SourceSAM
The Department of Energy, through its contractor TRIAD at Los Alamos National Laboratory (LANL), is announcing a technology licensing opportunity for an innovative protein-based system designed for the recovery and concentration of rare earth elements from complex liquid mixtures. This special notice, identified by procurement number S-193669, is not a solicitation for external development services, but rather an invitation for interested parties to explore licensing arrangements for this patented technology. Purpose and Scope: The primary objective of this technology is to provide a cleaner, more flexible, and environmentally conscious method for capturing and concentrating rare earth elements—critical materials essential to sectors such as energy, electronics, transportation, and advanced manufacturing. Traditional rare earth recovery processes are often environmentally damaging and inefficient. The LANL-developed system leverages a bio-inspired approach, utilizing engineered proteins to selectively bind and cluster rare earth metals, thereby simplifying their extraction from complex mixtures. Technical Overview and Key Features: At the core of this technology is a modified version of Lanmodulin, a protein known for its strong affinity to rare earth elements. By fusing an encapsulation peptide to the N-terminus of Lanmodulin, the engineered protein (EP-LanM) not only binds rare earth elements in solution but also self-assembles into larger biomolecular condensates upon metal binding. These condensates can be efficiently separated from the liquid phase using standard techniques such as centrifugation, filtration, or sedimentation, eliminating the need for immobilization on columns or fixed supports. The modularity of the protein architecture allows for adaptation with various Lanmodulin derivatives, enabling tailored selectivity for different rare earth elements without the need for a complete redesign. After metal recovery, the protein can be recycled for iterative use, further enhancing process sustainability. Expected Outcomes and Market Applications: The intended outcome is to provide licensees with a platform technology that supports more resilient and sustainable supply chains for critical materials. The system is particularly well-suited for applications in: - Critical minerals recovery from mixed metal streams - Mining and mineral processing, including low-grade sources and process waters - Waste recycling, especially for mixed recycling streams - Environmental remediation of metal-bearing waters and industrial residuals - Biomanufacturing and bioseparation, offering modular protein recovery tools Advantages of this technology include its bio-based nature, ability to concentrate rare earths from complex mixtures, avoidance of column-based immobilization, modular adaptability, and alignment with environmentally responsible recovery practices. Contracting Entity and Contact Information: The technology is offered by TRIAD, a Department of Energy contractor operating at Los Alamos National Laboratory in Los Alamos, New Mexico (NAICS Code 541714: Research and Development in Biotechnology, except Nanobiotechnology; Product Service Code AJ12). The licensing program is managed by the LANL Tech Partnerships office, which facilitates the transfer of patented and patent-pending inventions to commercial entities through exclusive or non-exclusive agreements. Interested parties are encouraged to contact Marc Witkowski or Lindsay Augustyn at [email protected] for further information or to initiate discussions regarding licensing opportunities. Procurement and Special Considerations: This is a special notice for technology licensing, not a procurement for goods or services. There are no set-aside requirements or external development solicitations associated with this opportunity. The technology is currently at Technology Readiness Level (TRL) 3 and is protected by a pending U.S. patent (reference LA-UR-26-25158). For additional details, including the full notice and related resources, please visit the official SAM.gov opportunity page: https://sam.gov/opp/4e2020f828f74da89f59a0e84400bd49/view. This opportunity remains active, with a response deadline of December 23, 2026. Contractors and companies with interests in biotechnology, critical materials recovery, or advanced separation technologies are encouraged to evaluate this licensing opportunity for alignment with their strategic objectives and capabilities.